Review article · 2023 · Open access
In vivo gene delivery to immune cells
Current Opinion in Biotechnology, 88, 103169 · Published 8 March 2023 · DOI 10.1016/j.copbio.2024.103169
In brief
“In vivo gene delivery to immune cells” is a 2023 review article by Jamison C. Siebart and 4 co-authors, published in Current Opinion in Biotechnology. OpenAlex counts 12 citations as of 18 November 2026. It is open access: the full text is free to read at Current Opinion in Biotechnology.
- Citations
- 12
- Most cited in
- 2026 (5)
- Field-weighted impact
- 0.36
- References
- 84
- Authors
- 5
Abstract
Immune cell therapies are an emerging class of living drugs that rely on the delivery of therapeutic transgenes to enhance, modulate, or restore cell function, such as those that encode for tumor-targeting receptors or replacement proteins. However, many cellular immunotherapies are autologous treatments that are limited by high manufacturing costs, typical vein-to-vein time of 3-4 weeks, and severe immune-related adverse effects. To address these issues, different classes of gene delivery vehicles are being developed to target specific immune cell subsets in vivo to address the limitations of ex vivo manufacturing, modulate therapeutic responses in situ, and reduce on- and off-target toxicity. The success of in vivo gene delivery to immune cells - which is being tested at the preclinical and clinical stages of development for the treatment of cancer, infectious diseases, and autoimmunity - is paramount for the democratization of cellular immunotherapies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Siebart, J. C., Chan, C. S., Yao, X., Su, F., & Kwong, G. A. (2023). In vivo gene delivery to immune cells. Current Opinion in Biotechnology, 88, 103169. https://doi.org/10.1016/j.copbio.2024.103169
MLA 9
Siebart, Jamison C., et al. “In vivo gene delivery to immune cells.” Current Opinion in Biotechnology, vol. 88, 2023, p. 103169. https://doi.org/10.1016/j.copbio.2024.103169.
Chicago
Siebart, Jamison C., Ching Shen Chan, Xinyi Yao, Fang‐Yi Su, and Gabriel A. Kwong. 2023. “In vivo gene delivery to immune cells.” Current Opinion in Biotechnology 88: 103169. https://doi.org/10.1016/j.copbio.2024.103169.
Harvard
Siebart, J. C. et al. (2023) ‘In vivo gene delivery to immune cells’, Current Opinion in Biotechnology, 88, p. 103169. doi:10.1016/j.copbio.2024.103169.
IEEE
J. C. Siebart, C. S. Chan, X. Yao, F. Su, and G. A. Kwong, “In vivo gene delivery to immune cells,” Current Opinion in Biotechnology, vol. 88, p. 103169, 2023, doi: 10.1016/j.copbio.2024.103169.
BibTeX
@article{siebart2023vivo,
title = {{In vivo gene delivery to immune cells}},
author = {Siebart, Jamison C. and Chan, Ching Shen and Yao, Xinyi and Su, Fang‐Yi and Kwong, Gabriel A.},
journal = {Current Opinion in Biotechnology},
year = {2023},
volume = {88},
pages = {103169},
doi = {10.1016/j.copbio.2024.103169},
url = {https://doi.org/10.1016/j.copbio.2024.103169}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2015 | 1 | |
| 2024 | 2 | |
| 2025 | 4 | |
| 2026 | 5 |
Its field-weighted citation impact is 0.36: it has been cited 0.36 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- in vivo gene delivery
- immune cells
- cellular immunotherapy
- gene carriers
- autologous cell therapy
- on-target off-tumor toxicity
- cancer immunotherapy
- autoimmunity
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Siebart, J. C., Chan, C. S., Yao, X., Su, F., & Kwong, G. A. (2023). In vivo gene delivery to immune cells. Current Opinion in Biotechnology, 88, 103169. https://doi.org/10.1016/j.copbio.2024.103169
How many times has this paper been cited?
12 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Current Opinion in Biotechnology: sign in and open the PDF from this page.
Who wrote this paper?
Jamison C. Siebart, Ching Shen Chan, Xinyi Yao, Fang‐Yi Su, Gabriel A. Kwong.
What is the DOI of this paper?
10.1016/j.copbio.2024.103169, permanently at https://doi.org/10.1016/j.copbio.2024.103169. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.